Profile
BLCO ISRG BDXA BDX ALC RMD
Company Name Bausch + Lomb Corporation Intuitive Surgical, Inc. Becton, Dickinson and Company Becton, Dickinson and Company Alcon Inc. ResMed Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies
Market Cap $5.49B $192.04B $55.91B $53.26B $37.61B $37.14B
Employees 13.50K 15.64K 0.00K 70.00K 25.60K 9.98K
CEO Brenton L. Saunders Gary S. Guthart - Thomas E. Polen Jr. David J. Endicott Michael J. Farrell BE, MBA, SM
Ratings
BLCO ISRG BDXA BDX ALC RMD
Quant Rating Score 2 3 5 3 3 4
Quant Rating Sell Neutral Strong Buy Neutral Neutral Buy
Trading
BLCO ISRG BDXA BDX ALC RMD
Last Close $15.47 $537.59 $59.24 $181.52 $73.6 $253.62
High 52 $20.65 $610.45 $59.24 $249.08 $98.3 $293.73
Low 52 $10.91 $429.59 $59.24 $165.15 $72.05 $204.58
Price vs. 52 Week High -25.08 % -11.94 % 0 % -27.12 % -25.13 % -13.66 %
Price vs. 52 Week Low 41.8 % 25.14 % 0 % 9.91 % 2.15 % 23.97 %
Total Return
BLCO ISRG BDXA BDX ALC RMD
1 Month Return 2.65 % 20.2 % 0 % -3.02 % -1.21 % -7.35 %
3 Month Return 12.84 % 7.41 % 0 % -0.01 % -17.49 % -8.58 %
6 Month Return 33.82 % 4.05 % 0 % -12.35 % -24.69 % 7.09 %
9 Month Return -12.35 % -7.34 % 0 % -26.95 % -20.28 % -1.56 %
YTD Return -14.34 % 2.99 % 0 % -19.99 % -13.3 % 10.9 %
1 Year Return -24.32 % 4.64 % 0 % -23.28 % -21.09 % 4.36 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
BLCO ISRG BDXA BDX ALC RMD
Dividend Yield Percentage (TTM) - - 2.26 % 2.24 % 0.44 % 0.86 %
Dividend Paid and Capex Coverage Ration (TTM) 0.53 % 4.3 % 1.73 % 1.73 % 3.26 % 4.34 %
Dividend Per Share (TTM) - - 4.16 % 4.16 % 0.33 % 2.19 %
Payout Ratio (TTM) - - 73.1 % 73.1 % 15.71 % 22.19 %
Growth
BLCO ISRG BDXA BDX ALC RMD
Asset Growth 0.2 % 8.54 %
Gross Profit Growth 16.57 % 11.69 %
Revenue Growth 15.15 % 4.16 %
Revenue 3 Year 26.15 % 5.3 %
Revenue 5 Year 25.72 % 8.72 %
Revenue 10 Year 29.59 % 59.37 %
EBIT Growth 52.14 % 19.82 %
Net Income Growth -21.92 % 14.89 %
Net Income 3 Yeari Growth Per Share -273.28 % -18.63 %
Net Income 5 Yeari Growth Per Share -205.83 % 28.82 %
Net Income 10 Yeari Growth Per Share -144.42 % -4.02 %
Operating Income Growth 24.62 % 13.55 %
Operating Cash Flow Growth (CFG) 1464.71 % 27.07 %
Operating 3 Year CFG -73.56 % -18.4 %
Operating 5 Year CFG -71.11 % 6.25 %
Operating 10 Year CFG -69.75 % 45.28 %
EPS Growth -21.62 % 18.31 %
EPS Diluted Growth -21.62 % 18.62 %
Book Value Per Share -5.78 % -0.85 %
Share Holder 3 Year Equity Growth Per Share -30.97 % 9.16 %
Share Holder 5 Year Equity Growth Per Share -35.34 % 14.4 %
Share Holder 10 Year Equity Growth Per Share - 241.78 %
Dividend Per Share Growth - -2.44 %
Dividend 3 Year Growth Per Share - 4.79 %
Dividend 5 Year Growth Per Share - 4.14 %
Dividend 10 Year Growth Per Share - 74.3 %
Debt Growth 4.87 % 31.74 %
Free Cash Flow Growth 70.2 % 45.25 %
Updated On 31 Dec 2024 30 Sep 2024
Profitability
BLCO ISRG BDXA BDX ALC RMD
Gross Profit Margin TTM 59.73 % 66.41 % 45.08 % 45.08 % 55.13 % 59.36 %
Return on Assets TTM -2.9 % 14.19 % 2.93 % 2.93 % 3.42 % 17.14 %
Return on Equity TTM -6.2 % 16.08 % 6.31 % 6.31 % 4.93 % 25.51 %
Return on Capital Employed TTM 0.3 % 16.05 % 5.78 % 5.78 % 4.98 % 23.55 %
Net Income Per EBT TTM 101.52 % 86.77 % 83.91 % 83.91 % 85.57 % 83.5 %
EBT Per Ebit TTM -1097.22 % 112.41 % 70.86 % 70.86 % 86.96 % 99.54 %
EBIT Per Revenue TTM 0.74 % 29.3 % 12.63 % 12.63 % 14.38 % 32.75 %
Cash Flow To Debt Ratio TTM 3.75 % - 16.82 % 16.82 % 39.27 % 198.52 %
Receivables Turnover TTM 4.49 7.63 7.27 7.27 4.98 5.48
Payables Turnover TTM 4.55 11.09 1.85 1.85 5.03 7.52
Inventory Turnover TTM 1.94 1.81 2.97 2.97 1.88 2.25
Fixed Asset Turnover TTM 290.89 % 186.61 % 313.67 % 313.67 % 197.54 % 716.47 %
Asset Turnover TTM 35.33 % 49.67 % 38.95 % 38.95 % 31.94 % 62.96 %
Operating Cash Flow Per Share TTM 0.53 8.3 11.3 11.3 4.16 11.96
Free Cash Flow Per Share TTM -0.47 6.37 8.85 8.85 3.23 11.32
Cash Per Share TTM 76.9 % 1376.56 % 262.85 % 262.85 % 284.33 % 825.72 %
Operating Cash Flow Sales Ratio TTM 3.81 % 30.8 % 15.22 % 15.22 % 20.57 % 34.04 %
Free Cash Flow Operating Cash Flow Ratio TTM -88.71 % 76.72 % 78.37 % 78.37 % 77.51 % 94.7 %
Cash Flow Coverage Ratios TTM 3.75 % - 16.82 % 16.82 % 39.27 % 198.52 %
Price To Free Cash Flows Ratio TTM -33.28 84.55 20.71 20.89 23.53 22.39
Price To Operating Cash Flows Ratio TTM 29.51 64.75 16.3 16.45 18.27 21.21
Price Cash Flow Ratio TTM 29.51 64.75 16.3 16.45 18.27 21.21
Income Statement (TTM)
BLCO ISRG BDXA BDX ALC RMD
Revenue $4.79B $8.35B $20.18B $20.18B $9.91B $5.15B
Gross Profit $2.92B $5.63B $9.13B $9.13B $5.51B $3.05B
Gross Profit Ratio 61.14% 67.46% 45.22% 45.22% 55.61% 59.36%
EBITDA $0.6B $2.81B $4.82B $4.82B $2.68B $1.91B
Net Income $-0.32B $2.32B $1.71B $1.71B $1.02B $1.4B
EPS Diluted -0.9 6.42 5.86 5.86 2.05 9.51
Balance Sheet (MRQ)
BLCO ISRG BDXA BDX ALC RMD
Long Term Debt $4.86B $0.11B $18.61B $18.61B $4.97B $0.81B
Total Liabilities $6.93B $2.31B $31.4B $31.4B $8.79B $2.21B
Total Equity $6.54B $16.53B $25.89B $25.89B $21.55B $5.97B
Total Investments $0.02B $7.05B $0.45B $0.45B $0.91B $0.09B
Total Debt $4.94B $0.15B $20.92B $20.92B $5.14B $0.88B
Total Assets $13.47B $18.84B $57.29B $57.29B $30.35B $8.17B
Cash Flow Statement (TTM)
BLCO ISRG BDXA BDX ALC RMD
Net Income $-0.31B $2.34B $1.71B $1.71B $1.02B $1.4B
Inventory $-0.15B $-0.83B $0.1B $0.1B $-0.05B $-0.08B
Dividends Paid $0B $0B $-1.1B $-1.1B $-0.13B $-0.31B
Operating Cash Flow $0.23B $2.42B $3.8B $3.8B $2.08B $1.75B
Capital Expenditure $-0.29B $-1.11B $-0.73B $-0.73B $-0.67B $-0.09B
Related Stocks
Ticker Name Price
AKYA Akoya Biosciences, Inc. 1.29
ALC Alcon Inc. 74.25
ANGO AngioDynamics, Inc. 12.135
APR Apria, Inc. 37.5
ATR AptarGroup, Inc. 124.26
ATRC AtriCure, Inc. 34.07
ATRI Atrion Corporation 459.92
ATRS Antares Pharma, Inc. 5.59
AVGR Avinger, Inc. 0.474
AVTR Avantor, Inc. 11.05
AZTA Azenta, Inc. 29.91
BAX Baxter International Inc. 19.175
BDX Becton, Dickinson and Company 179.285
BDXA Becton, Dickinson and Company 59.24
BDXB Becton, Dickinson and Company 48.16
BLFS BioLife Solutions, Inc. 26.91
COO The Cooper Companies, Inc. 70.1
DXR Daxor Corporation 13.36
EKSO Ekso Bionics Holdings, Inc. 5.09
FEMY Femasys Inc. 0.6185
ETFs With Exposure to BLCO
Ticker ETF Name Weight Percentage Price
FPX First Trust US Equity Opportunities ETF 0.43 167.02
PDN Invesco FTSE RAFI Developed Markets ex-U.S. Small-Mid ETF 0.03 41.21
CZA Invesco Zacks Mid-Cap ETF 0.324 108.918
PWC Invesco Dynamic Market ETF 0.353 37.8843
XCV.TO iShares Canadian Value Index ETF 0.07374 47.83
BBCA JPMorgan BetaBuilders Canada ETF 0.04 87.04
BKMC BNY Mellon US Mid Cap Core Equity ETF 0.02 107.78
BKSE BNY Mellon US Small Cap Core Equity ETF 0.03 110.98
BMED BlackRock Future Health ETF 0.38821 28.36
GUSA Goldman Sachs MarketBeta U.S. 1000 Equity ETF 0 59.2438
DFIC Dimensional International Core Equity 2 ETF 0.00035485 33.01
AGED.L iShares Ageing Population UCITS ETF 0.06105 9.1425
DFSI Dimensional International Sustainability Core 1 ETF 0.00534105 41.31
AGES.L iShares Ageing Population UCITS ETF 0.06105 694.875
2B77.DE iShares Ageing Population UCITS ETF 0.06105 7.882
FSYD Fidelity Sustainable High Yield ETF 0.01 48.3795
DFAX Dimensional World ex U.S. Core Equity 2 ETF 0.00175465 31.8
QWST Harbor ETF Trust - Harbor Small Cap Explorer ETF 0.5 32.0152
Unlock